Abeona Therapeutics (ABEO) Stocklytics Forecast

Abeona Therapeutics Inc (ABEO) is a biopharmaceutical company that focuses on developing gene and cell therapies for rare genetic diseases. The company's stock price has been a subject of interest for investors and analysts, with many trying to predict its future performance. While it is challenging to accurately forecast stock prices, there are various factors that can influence ABEO's stock price in the coming years.

One important aspect to consider is the progress of Abeona Therapeutics' pipeline. The company is currently developing several potential therapies for rare diseases like Sanfilippo syndrome, EB-101 for recessive dystrophic epidermolysis bullosa, and ABO-202 for CLN1 disease. Positive results from clinical trials and regulatory approvals can significantly impact the stock price in a positive way. Conversely, setbacks in clinical trials or regulatory challenges may negatively affect the stock.